A historical perspective on clinical trials innovation and leadership: Where have the academics gone?

JAMA

Volumn 305, Issue 7, 2011, Pages 713-714

  DeMets, David L ^a   Califf, Robert M ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; CLINICAL TRIAL (TOPIC); DRUG APPROVAL; DRUG LABELING; FOOD AND DRUG ADMINISTRATION; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH INSURANCE; HUMAN; LEADERSHIP; MEDICAL RESEARCH; METHODOLOGY; NOTE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); UNITED STATES;

EID: 79951696690     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.175     Document Type: Note

References (10)

1. Clancy C, Collins FS. Patient-Centered Outcomes Research Institute: the intersection of science and health care. Sci Transl Med. 2010;2(37):cm18.
2. Olsen LA, Dara Aisner D, McGinnis JM, eds. Institute of Medicine Roundtable on Evidence-Based Medicine: The Learning Healthcare System (Workshop Summary). Washington, DC: National Academies Press; 2007.
3. Fisher ES, McClellan MB, Bertko J, et al. Fostering accountable health care: moving forward in medicare. Health Aff (Millwood). 2009;28(2):w219-w231.
4. Organization, review, and administration of cooperative studies (Greenberg Report): a report from the Heart Special Project Committee to the National Advisory Heart Council, May 1967. Control Clin Trials. 1988;9(2):137-148.
5. Coronary Drug Project Research Group. The Coronary Drug Project: design, methods, and baseline results. Circulation. 1973;47(suppl 1):11-179.
6. Friedman L, Furberg C, DeMets D. Fundamentals of Clinical Trials. 4th ed. New York, NY: Springer; 2010.
7. Fisher MR, Roecker EB, DeMets DL. The role of an independent statistical analysis center in the industry-modified National Institutes of Health model. Drug Inf J. 2001;35:115-129. (Pubitemid 32198560)
8. Eisenstein EL, Collins R, Cracknell BS, et al. Sensible approaches for reducing clinical trial costs. Clin Trials. 2008;5(1):75-84. (Pubitemid 351412376)
9. DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: new estimates of drug development costs. J Health Econ. 2003;22(2):151-185. (Pubitemid 36279392)
10. Psaty BM, Rennie D. Stopping medical research to save money: a broken pact with researchers and patients. JAMA. 2003;289(16):2128-2131. (Pubitemid 37430215)